Donate For Public and Patients Store Search

S015 - Bureaucracy, Compliance, and Burnout: What it Means to Dermatologists

Friday, March 1; 1:00 PM - 4:00 PM

Learning Objectives

Following this course, the attendee should be able to:

  • Identify the regulatory, social, and professional forces leading to feelings of frustration, dejection, and hopelessness for American dermatologists.
  • Identify forces in our day-to-day lives that lead to professional burnout.
  • Formulate strategies for lifelong success and happiness as a dermatologist.

Description

In this audience-focused symposium, experts will discuss the wide range of factors leading to frustration, anxiety, and dissatisfaction for dermatologists, including the impact of government bureaucracy, social media, non-dermatologist encroachment, and false advertising. Participation from attendees is encouraged.

Disclosures

  • Bhatia, Neal D., MD: AbbVie – I(Grants/Research Funding); Aclaris Therapeutics, Inc. – I(Grants/Research Funding); Actavis – I(Grants/Research Funding); Allergan, Inc – C(H); Almirall – C(H); Asana Biosciences, LLC – I(Grants/Research Funding); Atacama Therapeutics – I(Grants/Research Funding); Biofrontera AG – C(H); BioPharmX – I(Grants/Research Funding); BMS – I(Grants/Research Funding); Brickell Biotech, Inc. – I(Grants/Research Funding); Crown Laboratories, Inc. – I(Grants/Research Funding); Cutanea Life Sciences – I(Grants/Research Funding); Dermira – I(Grants/Research Funding); Dr. Reddy – A(Grants/Research Funding); DUSA Pharmaceuticals, Inc. – I(Grants/Research Funding); Ferndale Laboratories, Inc. – C(H); Foamix – I(Grants/Research Funding); Galderma Laboratories, L.P. – C(H); Glenmark Generics Inc. – I(Grants/Research Funding); IntraDerm Pharmaceuticals – C(H); ISDIN – C(H); Kiniksa Pharmaceuticals, Ltd. – I(Grants/Research Funding); La Roche-Posay Laboratorie Pharmaceutique – C(H); LEO Pharma, US – I(Grants/Research Funding); Mayne Pharma Group – C(H); MC2 Therapeutics – I(Grants/Research Funding); Menlo Therapeutics – I(Grants/Research Funding); Naked Biome, Inc. – I(Grants/Research Funding); Novartis Pharmaceuticals Corp. – C(H); Ortho Dermatologics – C(H); Par Pharmaceutical – I(Grants/Research Funding); Perrigo Company – I(Grants/Research Funding); Pfizer Inc. – I(Grants/Research Funding); Pierre Fabre Dermo-Cosmétique US – C(H); Promius Pharma, LLC – A(H); Realm Therapeutics – I(Grants/Research Funding); Sanofi/Regeneron – C(H), I(Grants/Research Funding); Sienna Biopharmaceuticals – I(Grants/Research Funding); Skinfix, Inc. – A(H); Sol-Gel Technologies – I(Grants/Research Funding); Soligenix, Inc – I(Grants/Research Funding); Strata Skin Sciences – I(Grants/Research Funding); Sun Pharmaceutical Industries Ltd. – C(H); UCB – I(Grants/Research Funding); Valeant Pharmaceuticals International – C(H); Vidac Pharma – I(Grants/Research Funding); Vyome Therapeutics Limited – C(Grants/Research Funding);
  • Kaufmann, Mark D., MD: BioPharmX – C(Fees); Castle Biosciences, Inc – C(Fees); Cutanea Life Sciences – C(Fees); Dermira – C(Fees); Galderma USA – C(Fees); IntraDerm Pharmaceuticals – C(Fees); ISDIN – C(Fees); Klara/Goderma, Inc. – C(SO); L'Oreal USA Inc. – C(Fees); La Roche-Posay Laboratorie Pharmaceutique – C(Fees); Modernizing Medicine – C(SO); MoleSafe, Inc. – O(Fees), O(ST); Ortho Dermatologics – C(Fees); Promius Pharma, LLC – C(Fees); SciBASE – C(Fees); Sensus Healthcare – A(H); Sun Pharmaceutical Industries Ltd. – C(Fees); UCB – C(Fees);
  • Knight, J. Matthew, MD: no financial relationships exist with commercial interests.
  • Murina, Andrea Tesvich, MD: AbbVie – SP(H); Celgene Corporation – SP(H); Janssen Biotech – SP(H); Novartis – SP(H);
  • Swanson, Elizabeth A., MD: Almirall – SP(H); Amgen – SP(H); Janssen Pharmaceuticals, Inc – A(H); Othro Dermatologics – SP(H); Pfizer Inc. – SP(H); Sanofi/Regeneron – SP(H);
Schedule
Friday, March 1
1:00 PM
Dr. Knight / Introduction/Bureaucracy & Burnout
1:10 PM
Dr. Kaufmann / Burnout and Private Equity: Savior or Satan?
1:30 PM
All faculty / Discussion/Q&A
1:50 PM
Dr. Bhatia / Patients vs. Doctors: One-Star Reviews, Yelp, and Social Media
2:10 PM
All faculty / Discussion/Q&A
2:30 PM
Dr. Murina / Am I Worthless?: Fake Derms, Independent Nurses, and $5 Botox
2:50 PM
All faculty / Discussion/Q&A
3:10 PM
Dr. Swanson / Solutions: Identifying and Mitigating Burnout in Dermatology
3:30 PM
All faculty / Concluding Thoughts and Audience Remarks
Event Details
  • Date
    Friday, March 1
  • Time
    1:00 PM - 4:00 PM
  • Location
    Room 140A
  • CME Credits
    3.00
  • Type
    Practice Management
Directors/Co-Directors
  • J. Matthew Knight, MD, FAAD
Speakers
  • Andrea Tesvich Murina, MD, FAAD
  • Elizabeth A. Swanson, MD, FAAD - Handout
  • Mark D. Kaufmann, MD, FAAD - Handout
  • Neal D. Bhatia, MD, FAAD - Handout